UTI - Dual Advantage Fixed Term Fund Series IV-IV (1997 Days) - Growth - Regular Plan

  • Previous Nav

  • Net Change on 23-01-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the Scheme is to generate income and reduce interest rate volatility by investing in fixed income securities that are maturing on or before the date of maturity of the Scheme and generate capital appreciation by investing in equity and equity related instruments. However there is no assurance that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
CRISIL Hybrid 85+15 - Conservative Index 0.70 2.47 11.82 8.04 8.48 8.85

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Fund Holdings as on 31-December-2019

  • GSEC RESERVE BANK OF INDIAMATURING 09/05/2022

  • GSEC RESERVE BANK OF INDIAMATURING 18/07/2022

  • NCD REC LTD

  • NCD INDIAN RAILWAYS FIN CORPN LTD.

  • C D AXIS BANK LTD.

  • NCD EXIM BANK

  • GSEC RESERVE BANK OF INDIAMATURING 22/06/2021

  • NCD SIKKA PORTS & TERMINALS LTD.

  • NET CURRENT ASSETS

  • EQ HDFC BANK LTD.

  • NCD NATIONAL BANK FOR AGRICULTURE & RURAL DEVELOPMENT

  • EQ INFOSYS LTD.

  • EQ DR REDDY'S LABORATORIES LTD.

  • EQ PHOENIX MILLS LTD

  • EQ ATUL LTD.

  • EQ NTPC LTD.

  • EQ MAHINDRA LIFESPACE DEVELOPERS LTD

  • EQ SUN PHARMACEUTICALS INDUSTRIES LTD.

  • EQ OIL & NATURAL GAS CORPORATION LTD.

  • NCD EXIM BANK

  • GSEC RESERVE BANK OF INDIAMATURING 15/03/2022

  • EQ DECCAN CEMENTS LTD.

  • FEDERAL BANK LTD STD - 371 DaysMargin deposit

View More
  • Miscellaneous

  • Bank - Private

  • Construction - Real Estate

  • Pharmaceuticals & Drugs

  • IT - Software

  • Chemicals

  • Power Generation/Distribution

  • Oil Exploration

  • Cement & Construction Materials

View More

About UTI - Dual Advantage Fixed Term Fund Series IV-IV (1997 Days)

Scheme Analysis

UTI - Dual Advantage Fixed Term Fund Series IV-IV (1997 Days) is a Hybrid - Balanced Hybrid Fund fund and belongs to UTI Mutual Fund. It was launched on 06-Mar-2017 and currently has an AUM of ₹24.02 crore. UTI - Dual Advantage Fixed Term Fund Series IV-IV (1997 Days) is benchmarked against CRISIL Hybrid 85+15 - Conservative Index as primary index.

The NAV of UTI - Dual Advantage Fixed Term Fund Series IV-IV (1997 Days) ended up ₹0(0.04%)yesterday to ₹11.6892.

Among its top 3 holdings the fund has exposure to GSEC RESERVE BANK OF INDIAMATURING 09/05/2022, and

The UTI - Dual Advantage Fixed Term Fund Series IV-IV (1997 Days) is managed by V. Srivatsa and Sunil Patil.

Fund House Contact

UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 66786666
service@uti.co.in
+91 (22) 66786503,56786578
www.utimf.com

Fund Manager

  • Cash

  • CRISIL-A1+

  • CRISIL-AAA

  • Deposits

  • Equity

  • Sov

View More